This website is intended for an international audience. To view your own country’s website if available, please select your country from the list provided.
Close
Close
Close
Close
Close
Close

Theramex News

Close

Our diverse portfolio helps us deliver on our commitment to Women's Health

Close

Get in touch

Our partners

Theramex is a leading global pharmaceutical company dedicated to women and their health, with a reputation for delivering impactful treatments to patients and driving value for our partners.

Learn more

News

2 October 2023

Theramex Announces Agreement to Acquire the European Rights to Duphaston® and Femoston® From Viatris, Inc.

Read more

14 August 2023

Theramex’s statement on the Women’s Health Strategy’s (WHS) one year anniversary

Read more

8 March 2023

Theramex enters into an exclusive licensing agreement with Radius Health Inc, to commercialise ELADYNOS® in the European Economic Area, the United Kingdom, Australia and Brazil

Read more